Antibodies against human NKG2D and uses thereof

Details for Australian Patent Application No. 2008337517 (hide)

Owner Novo Nordisk A/S

Inventors Svensson, Anders; Urso, Birgitte; Wagtmann, Peter Andreas Nicolai Reumert; Pedersen, Inger Lund

Agent Shelston IP

Pub. Number AU-A-2008337517

PCT Pub. Number WO2009/077483

Priority 08163163.2 28.08.08 EP; PCT/ EP2007/063979 14.12.07 EP

Filing date 15 December 2008

Wipo publication date 25 June 2009

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

10 June 2010 PCT application entered the National Phase

  PCT publication WO2009/077483 Priority application(s): WO2009/077483

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008337518-A cyano piperidinylphenil-oxazolidinone and use thereof.

2008337508-Compressible decorative paper impregnating agent which can be printed by the inkjet method